Tokio Marine Asset Management Co. Ltd. Has $284,000 Stake in Cardinal Health, Inc. (NYSE:CAH)
Tokio Marine Asset Management Co. Ltd. lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 25.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,650 shares of the company’s stock after selling 1,247 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Cardinal Health were worth $284,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of the company. Advisory Services Network LLC purchased a new stake in Cardinal Health during the first quarter valued at about $120,000. Quadrant Capital Group LLC raised its stake in Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock valued at $156,000 after buying an additional 116 shares during the period. Alpha Windward LLC raised its stake in Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock valued at $179,000 after buying an additional 17 shares during the period. MCF Advisors LLC raised its stake in Cardinal Health by 11.5% in the first quarter. MCF Advisors LLC now owns 2,478 shares of the company’s stock valued at $202,000 after buying an additional 256 shares during the period. Finally, First Mercantile Trust Co. raised its stake in Cardinal Health by 18.5% in the first quarter. First Mercantile Trust Co. now owns 2,539 shares of the company’s stock valued at $207,000 after buying an additional 397 shares during the period. 87.09% of the stock is currently owned by hedge funds and other institutional investors.
Cardinal Health, Inc. (NYSE:CAH) opened at 69.14 on Monday. Cardinal Health, Inc. has a 1-year low of $62.70 and a 1-year high of $84.90. The company has a 50 day moving average of $77.38 and a 200 day moving average of $77.27. The firm has a market capitalization of $21.85 billion, a P/E ratio of 17.16 and a beta of 0.80.
Cardinal Health (NYSE:CAH) last released its earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.14 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post $5.07 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Tokio Marine Asset Management Co. Ltd. Has $284,000 Stake in Cardinal Health, Inc. (NYSE:CAH)” was first posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/08/07/tokio-marine-asset-management-co-ltd-has-284000-stake-in-cardinal-health-inc-nysecah.html.
Several analysts have issued reports on CAH shares. Credit Suisse Group reaffirmed a “buy” rating and set a $81.00 price target on shares of Cardinal Health in a research report on Tuesday, May 2nd. Vetr raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 price target on the stock in a research report on Tuesday, June 13th. BidaskClub lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 11th. ValuEngine lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Jefferies Group LLC started coverage on shares of Cardinal Health in a research report on Wednesday, May 17th. They set a “hold” rating and a $77.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $80.46.
In other news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of Cardinal Health stock in a transaction on Friday, May 12th. The stock was sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the sale, the insider now directly owns 55,440 shares in the company, valued at approximately $4,039,912.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.94% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.